Integra LifeSciences Holdings (IART)

Financial leverage ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total assets	US$ in thousands	3,781,990	3,739,370	3,777,600	3,742,400	3,889,760	3,807,010	3,752,860	3,672,000	3,782,380	3,774,460	3,712,790	3,741,550	3,615,140	3,453,520	3,391,760	3,447,560	3,303,240	3,346,580	3,290,410	3,205,710
Total stockholders’ equity	US$ in thousands	1,587,880	1,579,220	1,683,160	1,674,940	1,804,400	1,724,410	1,660,920	1,615,200	1,684,800	1,631,690	1,574,980	1,529,330	1,514,870	1,397,990	1,349,100	1,341,800	1,416,740	1,384,970	1,420,950	1,397,030
Financial leverage ratio		2.38	2.37	2.24	2.23	2.16	2.21	2.26	2.27	2.25	2.31	2.36	2.45	2.39	2.47	2.51	2.57	2.33	2.42	2.32	2.29

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $3,781,990K ÷ $1,587,880K
= 2.38

Integra Lifesciences Holdings Corp's financial leverage ratio has exhibited a fluctuating trend over the past eight quarters. The ratio has been consistently above 2, reflecting a higher level of debt relative to equity in the company's capital structure. The ratio ranged between 2.16 and 2.38 during this period, indicating some variability in the extent of leverage being utilized. Overall, the company has maintained a relatively stable level of financial leverage, with minor fluctuations observed. It is crucial for stakeholders to closely monitor this ratio to assess the company's ability to meet its debt obligations and manage financial risks effectively.